These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36495880)

  • 21. Guselkumab: the First Selective IL-23 Inhibitor for Active Psoriatic Arthritis in Adults.
    Boehncke WH; Brembilla NC; Nissen MJ
    Expert Rev Clin Immunol; 2021 Jan; 17(1):5-13. PubMed ID: 33251833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generalized pustular psoriasis-like eruptions induced after the first use of adalimumab in the treatment of psoriatic arthritis.
    Kimura U; Kinoshita A; Haruna K; Mizuno Y; Sekigawa I; Takamori K; Suga Y
    J Dermatol; 2012 Mar; 39(3):286-7. PubMed ID: 21957978
    [No Abstract]   [Full Text] [Related]  

  • 23. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
    McInnes IB; Asahina A; Coates LC; Landewé R; Merola JF; Ritchlin CT; Tanaka Y; Gossec L; Gottlieb AB; Warren RB; Ink B; Assudani D; Bajracharya R; Shende V; Coarse J; Mease PJ
    Lancet; 2023 Jan; 401(10370):25-37. PubMed ID: 36493791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of psoriatic arthritis on ixekizumab clinical outcomes in moderate-to-severe psoriasis patients: A post hoc analysis.
    Gottlieb AB; Papp KA; Birbara CA; Shuler CL; Burge R; Erickson J; Kerr L; Mease PJ
    J Am Acad Dermatol; 2018 Sep; 79(3):593-595. PubMed ID: 29559395
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of ixekizumab in an HIV-positive patient with psoriatic arthritis.
    Qian F; Yan Y; Huang J; Xu W; Zhu Y; Liu J; Wu X; Chen F
    Int J STD AIDS; 2022 Apr; 33(5):519-521. PubMed ID: 35220812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation.
    Glatt S; Baeten D; Baker T; Griffiths M; Ionescu L; Lawson ADG; Maroof A; Oliver R; Popa S; Strimenopoulou F; Vajjah P; Watling MIL; Yeremenko N; Miossec P; Shaw S
    Ann Rheum Dis; 2018 Apr; 77(4):523-532. PubMed ID: 29275332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ustekinumab for resistant psoriatic arthritis.
    Wallis DE; Waldron NM; Korendowych E
    J Rheumatol; 2013 Feb; 40(2):207. PubMed ID: 23378500
    [No Abstract]   [Full Text] [Related]  

  • 28. Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.
    Saraceno R; Bavetta M; Zangrilli A; Chiricozzi A; Potenza C; Chimenti S; Chimenti MS
    Expert Opin Biol Ther; 2013 Sep; 13(9):1325-34. PubMed ID: 23930916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of secukinumab in psoriasis treatment.
    Berg SH; Balogh EA; Ghamrawi RI; Feldman SR
    Immunotherapy; 2021 Feb; 13(3):201-216. PubMed ID: 33203276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of inverse psoriasis successfully treated with adalimumab.
    Ješe R; Perdan-Pirkmajer K; Dolenc-Voljč M; Tomšič M
    Acta Dermatovenerol Alp Pannonica Adriat; 2014 Mar; 23(1):21-3. PubMed ID: 24638868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab.
    Megna M; Marano L; Camela E; Potestio L; Fabbrocini G; Scalvenzi M; Guerrasio G
    Dermatol Ther; 2022 Oct; 35(10):e15766. PubMed ID: 35959513
    [No Abstract]   [Full Text] [Related]  

  • 32. Secukinumab retreatment associated psoriasis flare with pustules.
    El-Komy M; Amer M; Mostafa A; ElKalioby M
    J Dermatolog Treat; 2022 Mar; 33(2):1107-1110. PubMed ID: 32538223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriasis treated with ustekinumab in a patient with hepatitis C.
    Abuchar A; Vitiello M; Kerdel FA
    Int J Dermatol; 2013 Mar; 52(3):381-2. PubMed ID: 23414168
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials.
    Mease PJ; Signorovitch J; Yu AP; Wu EQ; Gupta SR; Bao Y; Mulani PM
    Dermatology; 2010; 220(1):1-7. PubMed ID: 19940437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of severe psoriasis and psoriatic arthritis with adalimumab in an HIV-positive patient.
    Lindsey SF; Weiss J; Lee ES; Romanelli P
    J Drugs Dermatol; 2014 Jul; 13(7):869-71. PubMed ID: 25007373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review.
    Canavan TN; Elmets CA; Cantrell WL; Evans JM; Elewski BE
    Am J Clin Dermatol; 2016 Feb; 17(1):33-47. PubMed ID: 26649440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adalimumab therapy of psoriasis and psoriatic arthritis in a patient with cirrhosis of the liver.
    Piel S; Dissemond J
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S117-8. PubMed ID: 19119119
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of Psoriasis Arthritis Taking into Account New Treatment Options].
    Ryser C; Ciurea A
    Praxis (Bern 1994); 2018; 107(21):1147-1153. PubMed ID: 30326810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis.
    Bongiorno MR; Pistone G; Doukaki S; Aricò M
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S15-20. PubMed ID: 18837728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study.
    Gniadecki R; Bang B; Sand C
    Br J Dermatol; 2016 May; 174(5):1145-6. PubMed ID: 26522308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.